Q: As far as I can tell, the market worries about DSG seem to have all been tariff related. Is the impact of AI not something that is weighing on the stock valuation as well?
Q: Could you confirm how one should look at the total return for funds that use leverage to enhance yield? For example, I am showing growth of 13.16% on my initial investment in HMAX and it has a current “yield” of 12.48% so does that mean in the one year I have owned it I am up 25.64%? For HDIV, the numbers are 18.86% share growth and a 9.99% yield for total return of 28.85%? In past discussions of these products it doesn’t seem that what you see is always what you get!
Q: Hello. If I sell a US stock in a non-registered account for a loss, and I transfer the cash to my TFSA and re-purchase the same stock, can I still claim the capital loss?
Q: Rumours of a takeover bid by a US private equity firm. If bought what do you think would be a takeover price for CAE based on their market
capitalization and moat.
Q: I hold a position in Axon. 2025 has basically been a flat year for this stock. Do you see more upside in the future? Thank you for your excellent service.
Q: Wondering your thoughts on SN? My investment thesis is below, curious on your take?
Healthy top line growth, past and future with 10 consecutive quarters of organic double-digit top-line growth as of Q3 2025, also raised sales guidance which includes very conservative tariff estimates (i.e. high tariff rates)
Trading at 16x NTM earnings and 14x 2 years estimated earnings
Forecasting to approximately double cash flow over next two years
Debt/Equity of 0.4 and low net debt slightly above next years forecast cash flow
Plays into K shaped economy theme focussing on mid to upper tier consumers with discretionary, "nice to have" items
Motivated and capable leadership (featured in Bloomberg Businesweek recently), this is also confirmed by gross margin expansion through cost reduction during a difficult year for trade
Excellent marketing engine with proven track record using multiple sales channels (DTC, celebrity partneships, etc.)
Lots of success with new product lines, 25 introduced in 2025 and 3 that were category disruptors
Planning to significantly expand in Europe
Systematically reducing supply chain reliance on China
Q: As I do my year-end review, I am always looking for moves that can add potential ZIP for next year while being mindful of my senior years (old). My portfolio is well established in weighting and sectoral positioning. Chp.un has been in it since 2020 and has given me a 16% return (x div). It seems to have a muted outlook for 2026. What is your view on a switch to the somewhat out-of-favour car.un. At $37.80 ish and estimated up to $48 range next year, it seems like a solid move for growth potential. Not too worried about the minor div variance here. As always thank you for your service.
Q: Other than the yield, is there any significant difference between these 2 cash etfs? I currently have a substantial amount of cash in a money market fund. The return from CMR would be almost a full point higher. Is there any additional risk or downside to holding a cash etf vs a money market fund? Thank you for your help.
Q: I'm looking to deploy some funds outside of North America, for perspective my portfolio consists of mostly small, growth companies, I can handle very high volatility, and spend time daily managing my holdings and size positions. Have a couple of etf's that would fit my style?
Q: I don't like the way CDRs handle SPLITS "CIBC does not 'split' the CDRs in the typical sense. It instead adjusts the ratio of how many partial shares each CDR represents. This has been done now for NFLX."
Does it make sense to SELL my NFLX CDRs and BUY Regular NFLX on the Nasdaq??